{"id":27168,"date":"2026-06-26T21:26:00","date_gmt":"2026-06-26T19:26:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=b1de0a9aee759805ba886c341359cd75"},"modified":"2026-06-26T21:26:00","modified_gmt":"2026-06-26T19:26:00","slug":"deadline-alert-embecta-corp-embc-shareholders-who-lost-money-urged-to-contact-glancy-prongay-wolke-rotter-llp-about-securities-fraud-lawsuit","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=27168","title":{"rendered":"Deadline Alert: Embecta Corp. (EMBC) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit"},"content":{"rendered":"

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP<\/a> reminds investors of the upcoming August 17, 2026 <\/b>deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Embecta Corp. (\u201cEmbecta\u201d or the \u201cCompany\u201d) (NASDAQ: EMBC<\/a>) common stock between November 25, 2025 and May 4, 2026<\/b>, inclusive (the \u201cClass Period\u201d).<\/p><\/a><\/a>

IF YOU SUFFERED A LOSS ON YOUR EMBECTA INVESTMENTS, CLICK <\/b>HERE<\/b><\/a> TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS.<\/b><\/p>

What Happened?<\/b><\/p>

On May 5, 2026, Embecta released its second quarter fiscal 2026 financial results, revealing that revenue had declined over 14%, largely due to weakness in its pen needle sales. Additionally, the Company lowered its guidance for the remainder of fiscal 2026.<\/p>

On this news, Embecta\u2019s stock price fell $5.35, or 57.8%, to close at $3.90 per share on May 5, 2026, thereby injuring investors.<\/p>

What Is The Lawsuit About?<\/b><\/p>

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and\/or misleading statements, as well as failed to disclose material adverse facts about the Company\u2019s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the Company\u2019s guidance was misleading and unattainable; (2) segment weakness, especially in the United States pen needle market, was likely to disrupt the Company\u2019s original revenue guidance and second quarter 2026 results; and (3) as a result, Defendants\u2019 positive statements about the Company\u2019s business, operations, and prospects were materially misleading and\/or lacked a reasonable basis at all relevant times.<\/p>

If you purchased or otherwise acquired Embecta common stock during the Class Period, you may move the Court no later than August 17, 2026 <\/b>to request appointment as lead plaintiff in this putative class action lawsuit.<\/p>

Contact Us To Participate or Learn More:<\/b><\/p>

If you wish to\u202flearn more\u202fabout this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:<\/p>

Charles Linehan, Esq.,Glancy Prongay Wolke & Rotter LLP,1925 Century Park East, Suite 2100,Los Angeles California 90067Email: shareholders@glancylaw.com<\/a>Telephone: 310-201-9150,Toll-Free: 888-773-9224Visit our website at www.glancylaw.com<\/a>.Follow us for updates on LinkedIn<\/a>, Twitter<\/a>, or Facebook<\/a>.<\/p>

If you inquire by email, please include your mailing address, telephone number and number of shares purchased.<\/p>

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p> Contacts<\/b>

Glancy Prongay Wolke & Rotter LLP,1925 Century Park East, Suite 2100Los Angeles, CA 90067Charles Linehan<\/b>Email: shareholders@glancylaw.com<\/a>Telephone: 310-201-9150Toll-Free: 888-773-9224Visit our website at: www.glancylaw.com<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"

LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming August 17, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Embecta …<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-27168","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/27168","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=27168"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/27168\/revisions"}],"predecessor-version":[{"id":27169,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/27168\/revisions\/27169"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=27168"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=27168"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=27168"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}